Nearly every headline about Roundup cancer cases pictures the same person: a farmer on a tractor, a groundskeeper with a backpack sprayer, a professional who handled the product all day for a paycheck. So the most common question we hear from home users is a quiet, discouraged one — "I only used it in my own yard. Do I even count?" The honest answer is that home use is not a disqualifier. It is a fact pattern, and it has already been to trial and won.
Home Users Are a Real Category, Not an Afterthought
Roundup was never a professionals-only product. For decades it was one of the best-selling consumer weed killers in America, sold by the jug at hardware stores, garden centers, and big-box retailers to millions of ordinary homeowners. People used it the way the label invited them to: on lawns and flower beds, along fences and foundations, in the cracks of patios and driveways, around mailboxes and tree rings. A weekend gardener who mixed and sprayed most weekends through the growing season, year after year, was not a casual user in any meaningful sense. Over ten, twenty, or thirty years, that is a large number of applications and a real cumulative exposure.
That is the first thing to understand: eligibility does not turn on your job title. It turns on two things — a qualifying cancer diagnosis and a genuine, documentable history of exposure. A homeowner who sprayed for twenty summers can have a stronger exposure record than someone who used the product on the job for a single season. The law does not hand professionals a special key and lock everyone else out.
What the Science Says About Home Use — Honestly
We will not overstate the science, because overstating it does no one any good. The evidence linking glyphosate to non-Hodgkin lymphoma is strongest where exposure was highest and most sustained. In 2015, the World Health Organization's International Agency for Research on Cancer (IARC) classified glyphosate as "probably carcinogenic to humans" (Group 2A). A widely cited 2019 meta-analysis led by Luoping Zhang at the University of California, Berkeley, pooling the human studies, reported a 41% increased risk of non-Hodgkin lymphoma in the group with the highest cumulative glyphosate exposure. The key phrase there is highest exposure — dose and duration matter.
The picture for lighter, purely residential use is genuinely more mixed. The U.S. Environmental Protection Agency has maintained that glyphosate is "not likely to be carcinogenic to humans," and some case-control studies of home-and-garden herbicide use, considered on their own, did not detect an excess risk. This is exactly the IARC-versus-EPA disagreement at the heart of the litigation, and it is why an individual home user's case does not rest on a slogan. It rests on the specific facts: how concentrated the product was, how often it was applied, over how many years, with how much skin contact and inhalation, and what the diagnosis is. A serious residential exposure history is evaluated as a real dose, not waved off as "just yard work."
The Home Gardener Who Won: Hardeman v. Monsanto
If you want proof that a residential user can prevail, you do not have to speculate. Edwin Hardeman used Roundup to control poison oak, overgrowth, and weeds on his own Northern California property for roughly 26 years, from the mid-1980s until 2012. He was not a farmer and not a commercial applicator — he was a homeowner treating his own land. He was later diagnosed with non-Hodgkin lymphoma.
In 2019, a federal jury in the Northern District of California returned a verdict in Hardeman's favor. The trial judge reduced the award, and in May 2021 the U.S. Court of Appeals for the Ninth Circuit affirmed the judgment, in a published opinion (No. 19-16636). Hardeman's case became one of the most closely studied residential-use Roundup trials in the country. We mention it not as a promise — it is a reported past result, and past results never guarantee any particular outcome in another case — but because it answers the discouraged question directly. A home user's exposure has been found sufficient to support a jury verdict that survived appellate review.
One honest caveat that matters in 2026: Hardeman won on a failure-to-warn theory under the law as it stood then. As we explain below, the Supreme Court has since narrowed that specific theory. But the facts of his exposure — residential, decades-long, hands-on — remain the template for what a serious home-use history looks like.
Identifying the Product When the Jugs Are Long Gone
A worry we hear constantly: "I threw those bottles out years ago." That is normal, and it is not fatal to a case. You are not expected to have kept the containers. What the case needs is a reasonable reconstruction of what you used and how, and there are more sources for that than people assume.
- Product form. Consumer Roundup was sold as ready-to-use trigger sprays, hose-end applicators, and concentrates that you diluted yourself. Concentrates generally meant handling a stronger solution and more hands-on mixing — a relevant detail when we describe your exposure.
- Purchase trail. Store loyalty accounts, credit-card and bank statements, email receipts, and even old rewards histories can corroborate years of repeat purchases.
- Photographs and memory. Family photos of the yard, the shed, or the garage sometimes show the products. Your own detailed recollection — brand, container, sprayer type, how often, which seasons — is evidence.
- Witnesses. A spouse, adult children, or neighbors who watched you spray the same fence line every spring can confirm the pattern and duration.
Because so much residential glyphosate use involved multiple brands over the years — name-brand Roundup plus generic glyphosate products that flooded the market after the original patent expired — the analysis is rarely about a single jug. We address how mixed-product histories are handled in our guide on Roundup versus other glyphosate products and cumulative exposure.
Home Users Usually Have Less Protection, Not More
There is a counterintuitive point worth making. Professional applicators, at least in principle, work under safety frameworks — the federal Worker Protection Standard, employer-provided training, and personal protective equipment such as gloves, eyewear, and long sleeves. The typical homeowner had none of that. Many people sprayed in shorts and sandals on a warm afternoon, mixed concentrate over a kitchen sink or a garage bench, and pumped a handheld sprayer with bare hands, breathing the mist on a breezy day. From an exposure standpoint, the absence of protective equipment is not a weakness in a case — it can mean more direct skin contact and inhalation per application, not less. It is part of why a long residential history deserves to be taken seriously rather than dismissed.
Why the Theory We Lead With Survived the Supreme Court
Home users have understandably been unsettled by the 2026 headlines. On June 25, 2026, in Monsanto Co. v. Durnell, the Supreme Court held 7-2 that federal pesticide law preempts a state-law failure-to-warn claim — the argument that the label should have carried a cancer warning. We covered that ruling in detail in our full analysis of the Durnell decision. The short version for a home user is this: Durnell narrowed one theory. It did not declare Roundup safe, and it did not decide the theory our firm has led with from the start.
That theory is strict product liability based on design defect — the argument that the product was unreasonably dangerous as formulated, regardless of what the label said. A design-defect claim does not depend on whether the EPA required a cancer warning; it asks whether the formulation itself was defective. Nothing about that theory treats a homeowner differently from a farmer. The dangerous product in the jug was the same product on the shelf at the garden center. Whether any particular case — residential or occupational — can proceed after Durnell depends on its facts and on the theories available under the relevant state's law. That is a case-by-case question, and it is one worth asking rather than assuming the door is shut.
What Actually Makes a Home-Use Case
When we evaluate a residential exposure claim, we are really looking at the intersection of three things:
- A qualifying diagnosis. The cancers most consistently linked to glyphosate are non-Hodgkin lymphoma and its subtypes — including diffuse large B-cell lymphoma, follicular lymphoma, and chronic lymphocytic leukemia (CLL/SLL) — and we also evaluate multiple myeloma. At our firm, Herb Borroto, M.D., J.D., our Medical-Legal Expert, reads the pathology and the oncology records personally to confirm the diagnosis fits.
- A real exposure history. Duration and frequency are the drivers. Decades of regular seasonal use tell a very different story than a single afternoon, and we build that timeline carefully from the sources above.
- A theory that survives. After Durnell, that means anchoring the claim in design defect and strict liability rather than the label — the approach we have used against manufacturers before.
Every state also sets its own filing deadline, and the statute of limitations does not pause while the news cycle argues about preemption. If you are weighing whether your home use "counts," the safer move is to have the question answered on your specific facts before a deadline decides it for you. Our overview of who qualifies for a Roundup lawsuit walks through the categories in more detail.
Frequently Asked Questions
Can I file a Roundup lawsuit if I only used it at home in my own yard or garden?
Possibly. There is no rule that limits Roundup cancer claims to farmers or professional applicators. What matters is a qualifying diagnosis — such as non-Hodgkin lymphoma or a covered subtype — combined with a genuine, documentable exposure history. Many home users sprayed weekly for years or decades, which can add up to a substantial cumulative dose. Whether a residential-use case can proceed depends on the diagnosis, how much and how long you were exposed, the products involved, and the law of the relevant state. It is a case-by-case question, not a category that is automatically excluded.
Does it matter which Roundup product I used, or that I threw the bottles away years ago?
Product identification matters, but you do not need to have kept the containers. Consumer Roundup was sold in several forms — ready-to-use trigger sprays, hose-end applicators, and concentrates you mixed yourself — and after the early 2000s many generic glyphosate products entered the market too. We reconstruct which products you used and how through purchase records, store and card statements, photographs, product knowledge, and the accounts of family members and neighbors who saw you spray. Most homeowners no longer have the jugs, and that is normal and expected.
Has a home gardener who only used Roundup at home ever won a case?
Yes. Edwin Hardeman used Roundup on his own Northern California property to control poison oak and weeds for roughly 26 years and was later diagnosed with non-Hodgkin lymphoma. A federal jury returned a verdict in his favor in 2019; the trial judge reduced the award, and the U.S. Court of Appeals for the Ninth Circuit affirmed the judgment in 2021. Hardeman was a residential user, not a farmer or a commercial applicator. This is a reported past result; past results do not guarantee any particular outcome in another case, which always depends on its own facts.
After the Supreme Court's Durnell decision, can residential users still bring a claim?
Monsanto v. Durnell, decided June 25, 2026, held that federal pesticide law preempts a state failure-to-warn claim — the theory that the label should have carried a cancer warning. It did not decide, and did not foreclose, a design-defect or strict-liability claim that the product itself was unreasonably dangerous regardless of the label. That distinction applies to home users the same as to anyone else. Whether a specific residential-use case can move forward depends on its facts and on the theories available under the relevant state's law.
Bottom Line
If you used Roundup only at home and were later diagnosed with non-Hodgkin lymphoma or a related cancer, do not disqualify yourself before anyone has looked at your facts. Home use is a recognized fact pattern, a residential user's verdict has already been affirmed on appeal, and the design-defect theory that survived Durnell does not care whether the jug came off a farm supply pallet or a garden-center shelf. What a strong case needs is a confirmed qualifying diagnosis, a carefully built exposure history, and a theory that fits the law where you live. That is exactly what a free case review is for.
At our firm, Herb Borroto, M.D., J.D., our Medical-Legal Expert, reads the pathology, the immunohistochemistry, and the oncology charts himself, and Alex Alvarez, our Managing Partner and a Board Certified Civil Trial Lawyer, evaluates the legal theory each case can support. The review is exactly what it says: no obligation, and no fee unless we recover for you.